AI assistant
STAAR SURGICAL CO — Director's Dealing 2023
May 9, 2023
31996_dirs_2023-05-09_821f682f-9b45-4999-96fd-add548430c06.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2023-05-08
Reporting Person: Foust Warren (Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-05-08 | Common Stock | M | 20331 | $0.00 | Acquired | 20331 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-05-08 | Common Stock Options | $67.63 | M | 37567 | Acquired | 2033-05-07 | Common Stock (37567) | Direct |
Footnotes
F1: Award of 20,331 Restricted Stock Units of Common Stock (RSU), subject to forfeiture rights, which lapse as to 1/3 of the shares (6777) on 5/08/24, 1/3 of the shares (6777) on 5/08/25, and 1/3 of the shares (6777) on 5/08/26.
F2: The options granted become exercisable as follows: 1/3 on 5/08/2024 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 5/08/2026.